+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chantix"

Varenicline Market Report 2025 - Product Thumbnail Image

Varenicline Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Addictions Therapeutics Market Report 2025 - Product Thumbnail Image

Addictions Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nicotine Addiction Treatment Market Report 2025 - Product Thumbnail Image

Nicotine Addiction Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Chantix (varenicline) is a prescription medication used to help people quit smoking. It is a partial agonist of the nicotinic acetylcholine receptor, which helps reduce the craving and withdrawal symptoms associated with quitting smoking. It is also used to reduce the urge to smoke in people who are not ready to quit. Chantix is part of a larger class of drugs known as Addiction Disorders Drugs, which are used to treat various forms of addiction, including alcohol, opioids, and nicotine. Chantix is a popular choice for those looking to quit smoking, as it has been shown to be effective in helping people quit. It is also generally well-tolerated, with few side effects. However, it is important to note that Chantix is not a cure for nicotine addiction, and it is important to combine it with other forms of treatment, such as counseling and support groups. Some companies in the Chantix market include Pfizer, GlaxoSmithKline, and Mylan. Show Less Read more